At least three hedge funds were among the top shareholders of a biopharma company that was up by double-digits amid the market’s meltdown.
Stephen TaubSeptember 20, 2021
Bihua Chen, founder of Cormorant Asset Management.
(Alex Flynn/Bloomberg)
Finding stocks that finished in the green on Monday was sort of like playing Where’s Waldo.One of the very few winners, though, was a stock whose top shareholders are dominated by hedge funds.Shares of Atea Pharmaceuticals jumped more than 10 percent on Monday, closing at
To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.